Dranitsaris, G: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

The application of pharmacoeconomic modelling to estimate a value-based price for new cancer drugs

George Dranitsaris, Ilse Truter, Martie S. Lubbe, Wayne Cottrell, Biljana Spirovski, Jonathan Edwards

Journal:

Journal of Evaluation in Clinical Practice

Year:

2012

Language:

english

File:

PDF, 258 KB

english, 2012

2

The development of a value based pricing index for new drugs in metastatic colorectal cancer

George Dranitsaris, Ilse Truter, Martie S. Lubbe

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 157 KB

english, 2011

3

Biosimilars of Biological Drug Therapies

Dr George Dranitsaris, Eitan Amir, Kristine Dorward

Journal:

Year:

2011

Language:

english

File:

PDF, 144 KB

english, 2011

4

Improving the Cost Efficiency of PD-1/PD-L1 Inhibitors for Advanced Urothelial Carcinoma: A Major Role for Precision Medicine?

Sonpavde, Guru, Dranitsaris, George, Necchi, Andrea

Journal:

European Urology

Year:

2018

Language:

english

File:

PDF, 130 KB

english, 2018

5

Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness

Dranitsaris, George, Shane, Lesley G, Woodruff, Seth

Journal:

Journal of Oncology Pharmacy Practice

Year:

2017

Language:

english

File:

PDF, 193 KB

english, 2017

6

A structured group exercise program for patients with metastatic cancer receiving chemotherapy and CTNNB1 (β-catenin) as a biomarker of exercise efficacy

Chiarotto, James A, Akbarali, Riyad, Bellotti, Lara, Dranitsaris, George

Journal:

Cancer Management and Research

Year:

2017

Language:

english

File:

PDF, 484 KB

english, 2017

7

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

Dranitsaris, George, Jacobs, Ira, Kirchhoff, Carol, Popovian, Robert, Shane, Lesley G

Journal:

ClinicoEconomics and Outcomes Research

Year:

2017

Language:

english

File:

PDF, 250 KB

english, 2017

8

What are cancer patients willing to pay for prophylactic epoetin alfa? : A cost-benefit analysis

Ana Ortega, George Dranitsaris, Anitasha L. V. Puodziunas

Journal:

Year:

1998

Language:

english

File:

PDF, 98 KB

english, 1998

9

Author reply

George Dranitsaris

Journal:

Year:

1999

Language:

english

File:

PDF, 39 KB

english, 1999

10

A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases

Eitan Amir, Christine E. Simmons, Orit C. Freedman, George Dranitsaris, David E. C. Cole, Reinhold Vieth, Wei S. Ooi, Mark Clemons

Journal:

Year:

2010

Language:

english

File:

PDF, 208 KB

english, 2010

11

Sterile versus nonsterile gloves for repair of uncomplicated lacerations in the emergency department: A randomized controlled trial

Vsevolod S. Perelman, Gregory J. Francis, Tim Rutledge, John Foote, Frank Martino, George Dranitsaris

Journal:

Annals of Emergency Medicine

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

12

Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia

Eleftheria Hatzimichael, Leonidas Benetatos, Aggeliki Dasoula, George Dranitsaris, Stavroula Tsiara, Ioannis Georgiou, Maria Syrrou, Justin Stebbing, Helen M. Coley, Tim Crook, Konstantinos L. Bourant

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 297 KB

english, 2009

13

CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes

Leonidas Benetatos, Eleftheria Hatzimichael, Aggeliki Dasoula, George Dranitsaris, Stavroula Tsiara, Maria Syrrou, Ioannis Georgiou, Konstantinos L. Bourantas

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 401 KB

english, 2010

14

Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement

George Dranitsaris, Valentina Jelincic, Yoonhee Choe

Journal:

Thrombosis Journal

Year:

2011

Language:

english

File:

PDF, 657 KB

english, 2011

15

A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron

G. Dranitsaris, D. Warr, A. Puodziunas

Journal:

Supportive Care in Cancer

Year:

1995

Language:

english

File:

PDF, 694 KB

english, 1995

16

Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions

Leonidas Benetatos, Aggeliki Dasoula, Eleftheria Hatzimichael, Nelofer Syed, Maria Voukelatou, George Dranitsaris, Konstantinos L. Bourantas, Tim Crook

Journal:

Annals of Hematology

Year:

2011

Language:

english

File:

PDF, 247 KB

english, 2011

17

The autologous blood and marrow transplant long-term follow-up clinic: a model of care for following and treating survivors of autotransplant

Aaron D. Schimmer, George Dranitsaris, Val Ali, Margaret Falconer, Armand Keating

Journal:

Supportive Care in Cancer

Year:

2002

Language:

english

File:

PDF, 47 KB

english, 2002

18

Bisphosphonate use for the management of breast cancer patients with bone metastases: A survey of Canadian Medical Oncologists

Sunil Verma, Danielle Kerr-Cresswell, George Dranitsaris, Flay Charbonneau, Maureen Trudeau, Geetha Yogendran, Anne-Marie Cesta, Mark Clemons

Journal:

Supportive Care in Cancer

Year:

2004

Language:

english

File:

PDF, 119 KB

english, 2004

19

Severe chemotherapy-induced diarrhea in patients with colorectal cancer: a cost of illness analysis

George Dranitsaris, Jean Maroun, Amil Shah

Journal:

Supportive Care in Cancer

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

20

The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy

Mark Vincent, George Dranitsaris, Sunil Verma, Cathy Lau, Pere Gascon, Simon Van Belle, Heinz Ludwig

Journal:

Supportive Care in Cancer

Year:

2007

Language:

english

File:

PDF, 183 KB

english, 2007

21

Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis

George Dranitsaris, Haytham Khoury

Journal:

Supportive Care in Cancer

Year:

2011

Language:

english

File:

PDF, 217 KB

english, 2011

22

Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists

Nathaniel Bouganim, George Dranitsaris, Eitan Amir, Mark Clemons

Journal:

Supportive Care in Cancer

Year:

2011

Language:

english

File:

PDF, 167 KB

english, 2011

23

A pilot study to evaluate the feasibility of using willingness to pay as a measure of value in cancer supportive care: an assessment of amifostine cytoprotection

George Dranitsaris

Journal:

Supportive Care in Cancer

Year:

1997

Language:

english

File:

PDF, 246 KB

english, 1997

24

Cost utility analysis of prophylactic pamidronate for the prevention of skeletal related events in patients with advanced breast cancer

G. Dranitsaris, Tom Hsu

Journal:

Supportive Care in Cancer

Year:

1999

Language:

english

File:

PDF, 73 KB

english, 1999

25

Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study

George Dranitsaris, Pauline Leung, David Warr

Journal:

Supportive Care in Cancer

Year:

2001

Language:

english

File:

PDF, 50 KB

english, 2001

26

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death

Eileen Rakovitch, Jean-Philippe Pignol, Carole Chartier, Michelle Ezer, Sunil Verma, George Dranitsaris, Mark Clemons

Journal:

Breast Cancer Research and Treatment

Year:

2005

Language:

english

File:

PDF, 188 KB

english, 2005

27

A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy

Mark Clemons, George Dranitsaris, Wei Ooi, David E. C. Cole

Journal:

Breast Cancer Research and Treatment

Year:

2008

Language:

english

File:

PDF, 346 KB

english, 2008

28

The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines

George Dranitsaris, Daniel Rayson, Mark Vincent, Jose Chang, Karen Gelmon, David Sandor, Greg Reardon

Journal:

Breast Cancer Research and Treatment

Year:

2008

Language:

english

File:

PDF, 268 KB

english, 2008

29

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients

Orit Freedman, Eitan Amir, George Dranitsaris, Julie Napolskikh, Ritu Kumar, Michael Fralick, Stephen Chia, Teresa Petrella, Susan Dent, Katia Tonkin, Imran Ahmad, Daniel Rayson, Mark Clemons

Journal:

Breast Cancer Research and Treatment

Year:

2009

Language:

english

File:

PDF, 173 KB

english, 2009

30

nab-Paclitaxel weekly or every 3

George Dranitsaris, Robert Coleman, William Gradishar

Journal:

Breast Cancer Research and Treatment

Year:

2010

Language:

english

File:

PDF, 228 KB

english, 2010

31

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer

O. C. Freedman, E. Amir, W. Hanna, H. Kahn, F. O’Malley, G. Dranitsaris, D. E. C. Cole, S. Verma, E. Folkerd, M. Dowsett, M. Clemons

Journal:

Breast Cancer Research and Treatment

Year:

2010

Language:

english

File:

PDF, 257 KB

english, 2010

32

The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer

George Dranitsaris, William K. Evans, Debbie Milliken, Brent Zanke

Journal:

Journal of Evaluation in Clinical Practice

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

33

Baseline radiological staging in primary breast cancer: impact of educational interventions on adherence to published guidelines

Elaine McWhirter, Geetha Yogendran, Frances Wright, George Dranitsaris M. Pharm, Mark Clemons

Journal:

Journal of Evaluation in Clinical Practice

Year:

2007

Language:

english

File:

PDF, 65 KB

english, 2007

34

Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective

Couban, S, Dranitsaris, G, Andreou, P, Price, S, Tinker, L, Foley, R, Walker, I R, Jamal, S, Jamal, N, Spaner, D

Journal:

Bone Marrow Transplantation

Year:

1998

Language:

english

File:

PDF, 59 KB

english, 1998

35

Cost–Utility Analysis of Paclitaxel in Combination with Cisplatin for Patients with Advanced Ovarian Cancer

Ana Ortega, George Dranitsaris, Jeremy Sturgeon, Heather Sutherland, Amit Oza

Journal:

Gynecologic Oncology

Year:

1997

Language:

english

File:

PDF, 158 KB

english, 1997

36

Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients

George Dranitsaris, Eleftheria Hatzimichael

Journal:

Supportive Care in Cancer

Year:

2012

Language:

english

File:

PDF, 164 KB

english, 2012

37

Switching Breast Cancer Patients with Progressive Bone Metastases to Third-Generation Bisphosphonates: Measuring Impact Using the Functional Assessment of Cancer Therapy-Bone Pain

Reuben Broom, Hongyan Du, Mark Clemons, David Eton, George Dranitsaris, Christine Simmons, Wei Ooi, David Cella

Journal:

Journal of Pain and Symptom Management

Year:

2009

Language:

english

File:

PDF, 187 KB

english, 2009

38

Baseline radiological staging in early breast cancer: A comparison of practice guideline recommendations with actual clinical practice

M. Clemons, F. Wright, E. McWhirter, G. Dranitsaris, C. Holloway, F. Charbonneau, M. Trudeau, A. Smith, G. Yogendran, A. Mehlenbacher

Journal:

Year:

2003

Language:

english

File:

PDF, 190 KB

english, 2003

39

P97 Treatment of locally advanced breast cancer: Experience at a single Canadian institution

R. Dent, S. Verma, B. Fitzgerald, C. Holloway, P. Causer, F. Wright, G. Dranitsaris, J. Pignol, M. Trudeau, M. Clemons

Journal:

Year:

2005

Language:

english

File:

PDF, 150 KB

english, 2005

40

P170 The number needed to treat (NNT) as a measure of drug efficacy: the case of aromatase inhibitors (AIs) in post menopausal women with early breast cancer

H. Rugo, S. Kaura, G. Dranitsaris

Journal:

Year:

2007

Language:

english

File:

PDF, 43 KB

english, 2007

41

P102 Development of a risk prediction model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy

G. Dranitsaris, M. Clemons, S. Verma, M. Vincent

Journal:

Year:

2007

Language:

english

File:

PDF, 60 KB

english, 2007

42

0136 The number needed to treat to save a life: A comparison between aromatase inhibitors

H.S. Rugo, G. Dranitsaris, S. Kaura

Journal:

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

43

P285 A clinical comparison of letrozole or anastrozole for the treatment of hormone-positive breast cancer using indirect statistical techniques

G. Dranitsaris, S. Kaura

Journal:

Year:

2011

Language:

english

File:

PDF, 38 KB

english, 2011

44

The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia

Eleftheria Hatzimichael, Aggeliki Dasoula, Reshma Shah, Nelofer Syed, Alexandra Papoudou-Bai, Helen M. Coley, George Dranitsaris, Konstantinos L. Bourantas, Justin Stebbing, Tim Crook

Journal:

European Journal of Haematology

Year:

2010

Language:

english

File:

PDF, 127 KB

english, 2010

45

External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer

Christopher M Booth, George Dranitsaris, MCorona Gainford, Scott Berry, Michael Fralick, John Fralick, Joanna Sue, Mark Clemons

Journal:

Year:

2007

Language:

english

File:

PDF, 288 KB

english, 2007

46

The use of complementary and alternative medicines among patients with locally advanced breast cancer – a descriptive study

Lucy K Helyer, Stephen Chin, Betty K Chui, Barbara Fitzgerald, Sunil Verma, Eileen Rakovitch, George Dranitsaris, Mark Clemons

Journal:

Year:

2006

Language:

english

File:

PDF, 407 KB

english, 2006

47

Prevalence and Severity of Urogenital Symptoms in Postmenopausal Women Receiving Endocrine Therapy for Breast Cancer

Sheray N. Chin, Mateya Trinkaus, Christine Simmons, Candi Flynn, George Dranitsaris, Robyn Bolivar, Mark Clemons

Journal:

Clinical Breast Cancer

Year:

2009

Language:

english

File:

PDF, 616 KB

english, 2009

48

Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

Farrah Kassam, Katherine Enright, Rebecca Dent, George Dranitsaris, Jeff Myers, Candi Flynn, Michael Fralick, Ritu Kumar, Mark Clemons

Journal:

Clinical Breast Cancer

Year:

2009

Language:

english

File:

PDF, 117 KB

english, 2009

49

Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy

G. Dranitsaris, T.M. Tran

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 920 KB

english, 1995

50

Preemptive therapy with ganciclovir and short-course intravenous immunoglobulin does not prevent recurrent cytomegalovirus infection (CBMTG-102 study)

W.S. Hasegawa, G.R. Pond, G. Dranitsaris, G.G. Jenkins, S. Couban, I.R. Walker, J.H. Lipton

Journal:

Biology of Blood and Marrow Transplantation

Year:

2005

Language:

english

File:

PDF, 52 KB

english, 2005